title: Staphylococcus aureus bacteraemia management: where do we stand and where are we going?
authors.affiliation: Department of Medical Affairs, Cubist Pharmaceuticals, Lexington, Massachusetts, USA;
authors.forename: Pamela A
authors.initials: PA
authors.lastname: Moise
authors.affiliation: University of California San Diego, La Jolla, California, USA.
authors.forename: George
authors.initials: G
authors.lastname: Sakoulas
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016470:Bacteremia / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D017548:Echocardiography, Transesophageal; D004697:Endocarditis, Bacterial / Q000000981:diagnostic imaging*; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus; D013203:Staphylococcal Infections / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents
keywords: INFECTIOUS DISEASES